NCT00483977 - A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee | Biotech Hunter

Enrollment

113

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Osteoarthritis

Interventions

DRUG

Oxycodone

Oxycodone: oral controlled release, 20 mg, twice a day for 2 weeks

DRUG

Placebo

Placebo: oral for 2 weeks.

DRUG

PF-000592379

PF-00592379: oral, 30 mg, once a day for 2 weeks

Trial Locations (21)

23294

Pfizer Investigational Site, Richmond

27704

Pfizer Investigational Site, Durham

32720

Pfizer Investigational Site, DeLand

32779

Pfizer Investigational Site, Longwood

33021

Pfizer Investigational Site, Hollywood

33186

Pfizer Investigational Site, Miami

33486

Pfizer Investigational Site, Boca Raton

36608

Pfizer Investigational Site, Mobile

40213

Pfizer Investigational Site, Louisville

42431

Pfizer Investigational Site, Madisonville

45227

Pfizer Investigational Site, Cincinnati

45242

Pfizer Investigational Site, Cincinnati

63141

Pfizer Investigational Site, St Louis

85741

Pfizer Investigational Site, Tucson

89146

Pfizer Investigational Site, Las Vegas

95608

Pfizer Investigational Site, Carmichael

95628

Pfizer Investigational Site, Fair Oaks

95661

Pfizer Investigational Site, Roseville

95662

Pfizer Investigational Site, Orangevale

95825

Pfizer Investigational Site, Sacramento

10022-1009

Pfizer Investigational Site, New York